1. First‐in‐human study of ONO‐4578, an antagonist of prostaglandin E2 receptor 4, alone and with nivolumab in solid tumors. Issue 1 (4th November 2022) Authors: Iwasa, Satoru; Koyama, Takafumi; Nishino, Makoto; Kondo, Shunsuke; Sudo, Kazuki; Yonemori, Kan; Yoshida, Tatsuya; Tamura, Kenji; Shimizu, Toshio; Fujiwara, Yutaka; Kitano, Shigehisa; Shimomura, Akihiko; Sato, Jun; Yokoyama, Fumiharu; Iida, Hiroyuki; Kondo, Maki; Yamamoto, Noboru Journal: Cancer science Issue: Volume 114:Issue 1(2023) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗